HOME SCHEDULE REGISTRATION FRANÇAIS
Powered by liV Agency

For all enquiries:

Marie Goubran
marie.goubran@livagency.ca
(514) 220-2743
Nephrologists : 350 $
Nurses, Pharmacists, Dieticians: 85 $
Residents, Students, Others: 20 $

Saturday, November 30, 2024
8 AM to 2:30 PM

NEW LOCATION: To be held at The Westin Montréal:
270 Rue Saint-Antoine O, Montréal QC H2Y 0A3

REGISTER
Powered by liV Agency

For all enquiries:

Marie Goubran
marie.goubran@livagency.ca
514-220-2743
8:00 am
Early-Bird Conference (Summary of ASN Highlights)
  • Summarize four important studies presented at the 2024 ASN
  • Analyze the clinical pertinence of each of these studies
  • Apply appropriate learnings to clinical practice
9:00 am
Opening Remarks: Dr. Michel Vallée, JQH president
9:15 – 10:00 am
The Decision to End Dialysis: Clinical, ethical and communicational implications
Dr. Mathieu Moreau
  • Identify clinical situations in which a discussion on ending dialysis treatment would be justified
  • Assess the ethical and legal implications of the decision to end dialysis
  • Use effective communication strategies to initiate a conversation on ending dialysis treatment with the patient and the patient’s family
10:00 – 10:45 am
Osteoporosis in Hemodialysis
Dr. Fabrice Mac-Way
  • Identify hemodialysis patients who should be screened for fracture risk
  • Review the tools currently available to evaluate fracture risk
  • Implement an effective treatment approach for patients at high fracture risk
10:45 – 11:00 am
Health Break
11:00 – noon
Pierre-Nantel Conference
Why Should Incident Patients Be Treated with Incremental Hemodialysis (I-HD)?
Professor Patrick Saudan
  • How did we arrive at the current 4-hour, thrice weekly hemodialysis rubric?
  • Explain the importance of maintaining residual renal function (RRF) in hemodialysis patients
  • Describe current and upcoming studies on incremental dialysis
  • Assess the correlation between precision dialysis and patient QoL and survival rates
noon – 1:00 pm
Lunch
1:00 – 1:45 pm
Pregnancy in Hemodialysis
Dr. Dominique Genest
  • Offer adequate counseling to patients undergoing hemodialysis who want to become pregnant
  • Identify treatment goals and discuss the means to achieve them
  • Review the pharmacopoeia that can be safely used during pregnancy
1:45 – 2:30 pm
Fluid Buildup in Hemodialysis: New approaches to navigating troubled waters
Dr. William Beaubien-Souligny
  • Revisit the epidemiological data on fluid buildup and associated complications in patients on hemodialysis
  • Explore the potential role of technological tools such as lung ultrasound and bioimpedance to enhance clinical assessment accuracy
  • In light of the newly available data, evaluate the clinical efficacy of the various approaches to managing and treating fluid buildup
2:30 pm
Closing Remarks: Dr Michel Vallée